← Open Payments lookup

MISTI READY: Open Payments

NPI 1750696498 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$465 in 27 payments from 10 companies in 2025. Trend: 2023 $2,536 · 2024 $721 · 2025 $465

Food & beverage: $465
CompanyPaymentsAmount
Phathom Pharmaceuticals, Inc.11$152
QOL Medical, LLC3$69
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$59
Ipsen Biopharmaceuticals, Inc3$50
Takeda Pharmaceuticals U.S.A., Inc.2$36
Aimmune Therapeutics, Inc.1$22
GENZYME CORPORATION1$22
Regeneron Healthcare Solutions, Inc.1$21
Intercept Pharmaceuticals, Inc.1$19
Novo Nordisk Inc1$17

Products named: VOQUEZNA, Sucraid, XIFAXAN, IQIRVO, DUPIXENT, VOWST, ENTYVIO, OCALIVA.

Industry payments across MS — which companies pay providers there.